Inspira Secures US Patent for ART500 Respiratory Technology
Inspira Technologies (NASDAQ: IINN) has secured a crucial U.S. patent for its ART500 core technology, featuring low flow rates extracorporeal oxygenation system. The patent, which includes 16 novel claims and extends protection until 2043, positions Inspira to target an estimated $20 billion market for advanced respiratory support….